The rule is part of the Trump administration's objective to encourage competition in the health insurance markets and lower the cost of coverage. But experts say expanding access to association health plans could weaken the individual health insurance market.
The clock is officially ticking for clinicians hoping to earn a bonus under the Quality Payment Program in 2018. The program will reward clinicians who make the leap to a 2015-certified electronic health record system.
In response to the 21st Century Cures Act, the FDA outlined its regulatory approach in guidance documents about software as a medical device.
The agency's final guidance on additive manufacturing gives developers a clear pathway for getting their 3-D printed products approved.
As the deadline looms for Congress to act on a number of major funding priorities, anxiety grows among community health center providers as they fear their funding needs may be forgotten.
Providers are hoping CMS will move forward with its proposed six-month delay for home health agencies to implement a final rule aimed at improving their operations and patient care.
More oversight of disease awareness promotions could curb wasteful diagnostic testing, overdiagnosis and inappropriate therapy, researchers said.
The CMS last week notified 806,879 clinicians that they will not have to comply with Merit-based Incentive Payment System reporting requirements in 2017, potentially saving them millions collectively in compliance costs.
How to better understand a plan's appeals process and manage the wide range of challenges that follow its denial.
Wisconsin last week unveiled plans to overhaul Medicaid by requiring members to pay insurance premiums and undergo a drug screening.
Learn more specifically about MIPS and how to properly prepare for CMS' new program - the Quality Payment Program.
Certain circumstances, including if a medical device may pose a risk to patients, allows Brazil to suspend the registration of a medical device. Bayer disagreed with the decision, which it said had been made without the company's knowledge.